American Vanguard (AVD)
NYSE Market Open
American Vanguard Corporation is a specialty chemicals company focused primarily on crop protection, agricultural productivity, and pest management markets. Through its operating businesses, including the AMVAC brand, the company develops, manufactures, and markets products used by growers, commercial applicators, and consumers to protect crops, manage pests, and improve yields.
Its product portfolio spans synthetic, biological, and biorational solutions. These include insecticides, fungicides, herbicides, molluscicides, plant growth regulators, and soil fumigants sold in liquid, powder, and granular formulations. The breadth of formats allows American Vanguard to serve a range of agricultural practices and application methods, from row crops and specialty crops to non-crop and commercial uses.
The company operates in a highly regulated industry where product efficacy, safety, registration status, and stewardship are central to market access. Agricultural chemical demand is shaped by planted acreage, commodity prices, pest pressure, weather conditions, farmer income, and regulatory requirements. American Vanguard’s position is distinctive because it combines established chemical products with newer biological and biorational offerings, reflecting the sector’s gradual shift toward integrated pest management and more targeted crop-input strategies.
Beyond agriculture, some of its products serve commercial and consumer pest-control applications, broadening its end-market exposure. The company competes with larger global crop-science groups but focuses on specialty niches, product life-cycle management, formulation expertise, and distribution relationships. For investors, American Vanguard provides exposure to the agricultural inputs market, where long-term demand is linked to food production, crop protection needs, and the ongoing effort to improve farm efficiency while meeting safety and environmental standards.
Last updated
- Market Cap
- 70.66M
- P/E
- —
- P/FCF
- —
- P/S
- 0.14
- Enterprise Value
- 266.38M
- Sector
- —
- Industry
- —
- Address
- 4695 MACARTHUR COURT, NEWPORT BEACH, CA, 92660
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025
Global Bactericide Market Size To Worth USD 17.21 Billion By 2033 | CAGR of 4.8%
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
Kinross' (KGC) Earnings and Sales Surpass Estimates in Q1
Quaker Chemical's (KWR) Q1 Earnings Beat Estimates, Sales Lag
Valvoline (VVV) Surpasses Q2 Earnings and Revenue Estimates
Huntsman's (HUN) Q1 Earnings Beat Estimates, Revenues Miss
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
Westlake's (WLK) Earnings and Revenues Beat Estimates in Q1
FMC's Earnings Surpass Estimates, Revenues Lag in Q1
Valmont's (VMI) Q1 Earnings Beat Estimates, Revenues Miss
Scotts Miracle-Gro (SMG) Q2 Earnings & Sales Top Estimates
ArcelorMittal's (MT) Q1 Earnings and Revenues Beat Estimates
Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1
U.S. Steel's (X) Earnings and Revenues Lag Estimates in Q1
Carpenter Technology (CRS) Q3 Earnings Top Estimates, Surge Y/Y
Mosaic's (MOS) Q1 Earnings Top Estimates, Revenues Lag
Barrick (GOLD) Q1 Earnings Beat Estimates, Revenues Miss
Is Amerigo Resources (ARREF) Stock Outpacing Its Basic Materials Peers This Year?
CF Industries' (CF) Earnings and Sales Miss Estimates in Q1
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 70.66M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 266.38M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.37
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.14
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 11.96
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.51
- EPS
- -1.59
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -40.52M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -24.03%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -6.85%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 1.41
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.32
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.41
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.37
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 234.05K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 2.47
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 123.57M | 150.69M | 119.31M | 129.31M | 115.8M |
| Gross profit | 38.42M | 42.61M | 34.21M | 40.55M | 30.19M |
| Operating income | 1.89M | -21.85M | -6.75M | 4.37M | -4.31M |
| EBITDA | 7.24M | 8.06M | -2.05M | 9.04M | 439K |
| Net income | -4.15M | -28.21M | -12.36M | -849K | -8.46M |
| Basic EPS | -0.14 | -0.99 | -0.43 | -0.03 | -0.3 |
| Diluted EPS | -0.14 | -0.99 | -0.43 | -0.03 | -0.3 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 665.24M | 596.54M | 655.01M | 651.98M | 631.59M |
| Total liabilities | 475.62M | 404.14M | 434.03M | 421.16M | 404.23M |
| Total equity | 189.62M | 192.4M | 220.99M | 230.82M | 227.35M |
| Cash & equivalents | 70.91M | 12.43M | 16.8M | 14.48M | 11.81M |
| Current assets | 443.55M | 370.52M | 406.47M | 399.33M | 377.85M |
| Current liabilities | 190.92M | 209.45M | 230.17M | 208.74M | 213.07M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -35.44M | 5.95M | 12.69M | -19.26M | -20.58M |
| Investing cash flow | -973K | -1.57M | -985K | -611K | -446K |
| Financing cash flow | 95.01M | -8.36M | -9.42M | 21.68M | 19.8M |
| Change in cash | 58.6M | -3.97M | 2.29M | 1.81M | -1.22M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| form 4 | Form 4 — Gottschalk Patrick E | View Filing | |
| form 4 | Form 4 — Gottschalk Patrick E | View Filing | |
| form 4 | Form 4 — Gottschalk Patrick E | View Filing | |
| edgar index | 10-Q — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | DEF 14A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — AMERICAN VANGUARD CORP | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| form 4 | Form 4 — Kaye Douglas | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| form 4 | Form 4 — ROSENBLOOM KEITH M | View Filing | |
| form 4 | Form 4 — ROSENBLOOM KEITH M | View Filing | |
| form 4 | Form 4 — Bassett Mark R | View Filing | |
| form 4 | Form 4 — Gottschalk Patrick E | View Filing | |
| edgar index | UPLOAD — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | SCHEDULE 13G — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | SCHEDULE 13G — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | CORRESP — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 144 — AMERICAN VANGUARD CORP | View Filing | |
| form 4 | Form 4 — Eilers Peter | View Filing | |
| edgar index | UPLOAD — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | SCHEDULE 13G/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| form 4 | Form 4 — Gottschalk Patrick E | View Filing | |
| form 4 | Form 4 — Baskin Scott | View Filing | |
| form 4 | Form 4 — Macicek Steven D | View Filing | |
| form 4 | Form 4 — Gunter Emer | View Filing | |
| form 4 | Form 4 — Angelini Marisol | View Filing | |
| form 4 | Form 4 — Tiu de Mino Carmen | View Filing | |
| form 4 | Form 4 — Bassett Mark R | View Filing | |
| form 4 | Form 4 — ROSENBLOOM KEITH M | View Filing | |
| form 4 | Form 4 — ROSENBLOOM KEITH M | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | SCHEDULE 13G/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | SCHEDULE 13G/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | SCHEDULE 13G/A — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — AMERICAN VANGUARD CORP | View Filing | |
| form 4 | Form 4 — Kaye Douglas | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — AMERICAN VANGUARD CORP | View Filing | |
| edgar index | 8-K — AMERICAN VANGUARD CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing |